News

Rehaler receives 2.18 million DKK from the Danish Innovation Fund for new migraine treatment

The Innovation Fund has awarded Rehaler an Innobooster grant for the large scale clinical trial aiming to validate the effect of the...

Rehaler closes financing round of 6.1m DKK and strengthens Board of Directors with four experienced profiles.